Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
New chemotherapy protocol for canine lymphoma
Different protocols exist to treat lymphomas in dogs, almost all of them base on a remission protocol followed by a maintenance protocol. This study compares a maintenance-free chemotherapy protocol based on CHOP (H from hydroxydaunorubicin = doxorubicin, O from Oncovin = vincristine) to a similar protocol with a maintenance phase for the treatment of canine lymphoma.

Fifty-three dogs with multicentric lymphoma were treated with a 6-month modified version of the University of Wisconsin (UW)-Madison chemotherapy protocol (UW-25). Disease-free interval (DFI) and survival were compared to a historical control group of 55 dogs treated with a similar protocol with a prolonged maintenance phase. Remission rate for the study dogs was 94.2% (complete remission = 92.3%, partial remission = 1.9%). DFI and survival between the 2 groups did not differ significantly, with median DFI and survival of the study dogs equal to 282 and 397 days compared to 220 and 303 days for the control dogs (P = .2835 and .3365, respectively). Univariate analysis identified substage b (P = .0087), German Shepherd breed (P = .0199), and body weight > 18 kg (P = .0016) as significant for worse survival. Longer survival was associated with thrombocytopenia (P = .0436). Multivariate analysis revealed that substage (P = .0388) and weight (P = .0125) retained significance for DFI, whereas substage (P = .0093), thrombocytopenia (P = .0150), and weight (P = 0 .0050) retained significance for survival. Overall, the protocol was well tolerated by the dogs, with 41.5% (22/53) requiring a treatment delay or dose modification, but only 9.4% (5/53) needing hospitalization. The 6-month chemotherapy protocol based on CHOP with no maintenance phase provides similar DFI and survival times when compared to a similar protocol with a prolonged maintenance phase.


Source: Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM (2002): Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. In: J Vet Intern Med 2002 Nov-Dec;16(6):704-9






Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Prevalence of impinged spinous processes in asymptomatic dogsmembers
One hundred and ninety lateral thoracic radiographs of asymptomatic dogs radiographed for reasons other than spinal pain, were retrospectively reviewed by two board-certified radiologists. Images were assessed for impinged spinous processes and graded for narrowing, sclerosis or remodelling of the spinous processes.
How is the prevalence of impinged spinous processes in this group of dogs?

  • Intraocular pressure curve protocol for use in dogsmembers
  • Atopic dermatitis and the intestinal microbiota in dogs and menmembers
  • Bacterial contamination and DNA quantification in stored blood units members
  • Atypical chorioretinal coloboma in a Golden Retrievermembers
  • Oral direct factor Xa inhibitor anticoagulant in healthy adult horsesmembers
  • Use of three human cervical fusion implants in the canine cervical vertebral columnmembers
  • Radiotherapy for canine adrenocortical tumours with vascular invasionmembers
  • Intrahepatic portocaval shunt in dogs - diagnosis and therapymembers
  • Renal Abnormalities in Dogs with Coccidioidomycosismembers
  • Novel retinopathy in related Gordon settersmembers
  • Tolerability of a rapid-escalation vinblastine-prednisolone protocol in canine mast cell tumoursmembers
  • Retrospective Study of Feline Exocrine Pancreatic Insufficiencymembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved